Happydemics

Happydemics is a data analytics company specializing in brand lift measurement across diverse media channels, aimed at enhancing advertising profitability for its clients through actionable insights. Founded in 2015, Happydemics is headquartered in Paris, France, and focuses on brand lift measurement services. The company was established by Nicolas Trabuc and Tarek Ouagguini. It has completed a total of 7 deals, with the latest funding round being a Series B, raising EUR 13 million on December 3, 2024, co-led by Wille Finance and returning investor Adelie.

Happydemics has not undergone any significant pivots in its business strategy. Happydemics specializes in brand lift measurement across various media platforms, providing insights that enhance advertising profitability for its clients. Their primary offerings focus on tools that enable businesses to assess the effectiveness of their marketing campaigns, thus allowing for data-driven decision-making. The solutions are designed to address common challenges faced by brands, such as understanding consumer engagement and measuring campaign impact in real-time.

Targeting a diverse client base that includes advertisers and marketing agencies, Happydemics serves clients predominantly in Europe and North America, drawing in sectors that prioritize marketing analytics. By utilizing advanced methodologies to gauge brand perception, the company equips its users with actionable insights that inform advertising strategies and optimize media spend. Happydemics generated revenue of EUR 753,230. 50 in 2019 with an EBITDA of EUR -1,726,703.

50. The company generates revenue primarily through a subscription-based model, where clients pay for access to its analytics platform and reporting tools. This transactional structure typically involves partnerships with businesses looking to enhance their marketing effectiveness through data insights. Clients engage in contracts that may include tiered pricing plans based on the scale of their advertising campaigns and the depth of analytics required.

The company’s flagship services streamline the brand lift measurement process, facilitating a direct B2B exchange that emphasizes the value of data in optimizing ad performance. Through these structured agreements, Happydemics ensures consistent revenue flow while delivering measurable outcomes to its clientele. In December 2024, Happydemics raised EUR 13 million in Series B funding to expand its market reach in the UK. The funding will be used to support the introduction of new products tailored to meet the evolving needs of clients and to establish a stronger presence in previously untapped regions.

The company aims to leverage this investment to enhance its analytics capabilities and further its strategic expansion initiatives.